TG Therapeutics
TGTX
TGTX
116 hedge funds and large institutions have $434M invested in TG Therapeutics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 44 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 113 → 116 (+3)
0.6% more ownership
Funds ownership: 54.7% → 55.31% (+0.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
116
Holding in Top 10
1
Calls
$17M
Puts
$3.71M
Top Buyers
| 1 | +$16.9M | |
| 2 | +$8.65M | |
| 3 | +$7.87M | |
| 4 |
BlackRock
New York
|
+$7.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.76M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$10.5M | |
| 3 | -$5.09M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.01M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.52M |